Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer-Reference-Cited by-同舟云学术

Blood serum proteins as biomarkers for prediction of survival, locoregional control and distant metastasis rate in radiotherapy and radio-chemotherapy for non-small cell lung cancer

Published:2019-05-08 Issue:1 Volume:19 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Suwinski Rafał^ORCID,Giglok Monika,Galwas-Kliber Katarzyna,Idasiak Adam,Jochymek Bozena,Deja Regina,Maslyk Barbara,Mrochem-Kwarciak Jolanta,Butkiewicz Dorota

Funder

Polish National Science Centre

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-019-5617-1.pdf

Reference33 articles.

1. Syrigos K, Fiste O, Charpidou A, Grapsa D. Circulating tumor cell count as a predictor of survival in lung cancer. Crit Rev Oncol Hematol. 2018;25:60–8.

2. Paci M, Maramotti S, Bellesia E, Formisano D, Albertazzi L, Ricchetti T, Ferrari G, Annessi V, Lasagni D, Carbonelli C, et al. Circulating plasma DNA as a diagnostic biomarker in non-small cell lung cancer. Lung Cancer. 2009;64(1):92–7.

3. Suwinski R, Klusek A, Tyszkiewicz T, et al. Gene expression from bronchoscopy obtained tumour samples as a predictor of outcome in advanced inoperable lung cancer. PLoS One. 2012;7(7):e41379.